{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:52:53Z","timestamp":1771955573618,"version":"3.50.1"},"publisher-location":"Cham","reference-count":68,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319952871","type":"print"},{"value":"9783319952888","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/112_2018_9","type":"book-chapter","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T01:03:20Z","timestamp":1524704600000},"page":"47-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Potential of Cationic Liposomes as Adjuvants\/Delivery Systems for Tuberculosis Subunit Vaccines"],"prefix":"10.1007","author":[{"given":"Farzad","family":"Khademi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramezan Ali","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Abbas","family":"Momtazi-Borojeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Farnoosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003116","volume":"3","author":"EM Agger","year":"2008","unstructured":"Agger EM, Rosenkrands I, Hansen J, Brahimi K, Vandahl BS, Aagaard C et al (2008) Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One 3:e3116","journal-title":"PLoS One"},{"issue":"12","key":"9_CR2","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/jcb.26070","volume":"118","author":"P Ahmaditabar","year":"2017","unstructured":"Ahmaditabar P, Momtazi-Borojeni AA, Rezayan AH, Mahmoodi M, Sahebkar A, Mellat M (2017) Enhanced entrapment and improved in vitro controlled release of N-acetyl cysteine in hybrid PLGA\/lecithin nanoparticles prepared using a nanoprecipitation\/self-assembly method. J Cell Biochem 118(12):4203\u20134209","journal-title":"J Cell Biochem"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/17425247.2016.1151871","volume":"13","author":"CR Alving","year":"2016","unstructured":"Alving CR, Beck Z, Matyas GR, Rao M (2016) Liposomal adjuvants for human vaccines. Expert Opin Drug Deliv 13:807\u2013816","journal-title":"Expert Opin Drug Deliv"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","volume":"15","author":"P Andersen","year":"2007","unstructured":"Andersen P (2007) Vaccine strategies against latent tuberculosis infection. Trends Microbiol 15:7\u201313","journal-title":"Trends Microbiol"},{"key":"9_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018523","volume":"4","author":"P Andersen","year":"2014","unstructured":"Andersen P, Kaufmann SH (2014) Novel vaccination strategies against tuberculosis. Cold Spring Harb Perspect Med 4:a018523","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","volume":"27","author":"E Badell","year":"2009","unstructured":"Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A et al (2009) Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-\u03b3 producing T-cells. Vaccine 27:28\u201337","journal-title":"Vaccine"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.exppara.2012.09.001","volume":"132","author":"A Badiee","year":"2012","unstructured":"Badiee A, Khamesipour A, Samiei A, Soroush D, Shargh VH, Kheiri MT et al (2012) The role of liposome size on the type of immune response induced in BALB\/c mice against leishmaniasis: rgp63 as a model antigen. Exp Parasitol 132:403\u2013409","journal-title":"Exp Parasitol"},{"key":"9_CR8","first-page":"122","volume":"20","author":"AA Baghani","year":"2017","unstructured":"Baghani AA, Soleimanpour S, Farsiani H, Mosavat A, Yousefi M, Meshkat Z et al (2017) CFP10: mFc\u03b32 as a novel tuberculosis vaccine candidate increases immune response in mouse. Iran J Basic Med Sci 20:122","journal-title":"Iran J Basic Med Sci"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","volume":"33","author":"D Bottai","year":"2015","unstructured":"Bottai D, Frigui W, Clark S, Rayner E, Zelmer A, Andreu N et al (2015) Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. Vaccine 33:2710\u20132718","journal-title":"Vaccine"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jconrel.2014.06.027","volume":"190","author":"LA Brito","year":"2014","unstructured":"Brito LA, O\u2019Hagan DT (2014) Designing and building the next generation of improved vaccine adjuvants. J Control Release 190:563\u2013579","journal-title":"J Control Release"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1016\/j.vaccine.2005.03.024","volume":"23","author":"H Cai","year":"2005","unstructured":"Cai H, Hu X, Yu D, Li S, Tian X, Zhu Y (2005) Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Vaccine 23:4167\u20134174","journal-title":"Vaccine"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tips.2011.06.003","volume":"32","author":"AM Checkley","year":"2011","unstructured":"Checkley AM, McShane H (2011) Tuberculosis vaccines: progress and challenges. Trends Pharmacol Sci 32:601\u2013606","journal-title":"Trends Pharmacol Sci"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/14760584.6.5.785","volume":"6","author":"D Christensen","year":"2007","unstructured":"Christensen D, Korsholm KS, Rosenkrands I, Lindenstr\u00f8m T, Andersen P, Agger EM (2007) Cationic liposomes as vaccine adjuvants. Expert Rev Vaccines 6:785\u2013796","journal-title":"Expert Rev Vaccines"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/08982100902726820","volume":"19","author":"D Christensen","year":"2009","unstructured":"Christensen D, Agger EM, Andreasen LV, Kirby D, Andersen P, Perrie Y (2009) Liposome-based cationic adjuvant formulations (CAF): past, present, and future. J Liposome Res 19:2\u201311","journal-title":"J Liposome Res"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.colsurfb.2009.05.013","volume":"73","author":"LG Torre de la","year":"2009","unstructured":"de la Torre LG, Rosada RS, Trombone APF, Frantz FG, Coelho-Castelo AA, Silva CL et al (2009) The synergy between structural stability and DNA-binding controls the antibody production in EPC\/DOTAP\/DOPE liposomes and DOTAP\/DOPE lipoplexes. Colloids Surf B Biointerfaces 73:175\u2013184","journal-title":"Colloids Surf B Biointerfaces"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","volume":"174","author":"J Dietrich","year":"2005","unstructured":"Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM et al (2005) Exchanging ESAT6 with TB10. 4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174:6332\u20136339","journal-title":"J Immunol"},{"key":"9_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005139","volume":"4","author":"T Elvang","year":"2009","unstructured":"Elvang T, Christensen JP, Billeskov R, Hoang TTKT, Holst P, Thomsen AR et al (2009) CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10. 4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS One 4:e5139","journal-title":"PLoS One"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jconrel.2015.04.010","volume":"208","author":"Y Fan","year":"2015","unstructured":"Fan Y, Sahdev P, Ochyl LJ, Akerberg JJ, Moon JJ (2015) Cationic liposome\u2013hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. J Control Release 208:121\u2013129","journal-title":"J Control Release"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1039\/C6MB00174B","volume":"12","author":"H Farsiani","year":"2016","unstructured":"Farsiani H, Mosavat A, Soleimanpour S, Sadeghian H, Eydgahi MRA, Ghazvini K et al (2016) Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6: CFP-10 complex. Mol BioSyst 12:2189\u20132201","journal-title":"Mol BioSyst"},{"issue":"1","key":"9_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/21691401.2017.1290646","volume":"46","author":"M Fasihi-Ramandi","year":"2018","unstructured":"Fasihi-Ramandi M, Ghobadi-Ghadikolaee H, Ahmadi-Renani S, Taheri RA, Ahmadi K (2018) Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype. Artif Cells Nanomed Biotechnol 46(1):56\u201361. \n                  https:\/\/doi.org\/10.1080\/21691401.2017.1290646","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/erv.11.29","volume":"10","author":"N Gar\u00e7on","year":"2011","unstructured":"Gar\u00e7on N, Van Mechelen M (2011) Recent clinical experience with vaccines using MPL-and QS-21-containing adjuvant systems. Expert Rev Vaccines 10:471\u2013486","journal-title":"Expert Rev Vaccines"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/22103031113036660015","volume":"4","author":"T Garg","year":"2014","unstructured":"Garg T, Goyal AK (2014) Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4:62\u201371","journal-title":"Drug Deliv Lett"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1016\/j.vaccine.2005.07.045","volume":"23","author":"MP Girard","year":"2005","unstructured":"Girard MP, Fruth U, Kieny M-P (2005) A review of vaccine research and development: tuberculosis. Vaccine 23:5725\u20135731","journal-title":"Vaccine"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1517\/14712598.4.7.1139","volume":"4","author":"R Gl\u00fcck","year":"2004","unstructured":"Gl\u00fcck R, Moser C, Metcalfe IC (2004) Influenza virosomes as an efficient system for adjuvanted vaccine delivery. Expert Opin Biol Ther 4:1139\u20131145","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"9_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i3.10","volume":"19","author":"M Hashida","year":"2002","unstructured":"Hashida M, Opanasopit P, Nishikawa M (2002) Factors affecting drug and gene delivery: effects of interaction with blood components. Crit Rev Ther Drug Carrier Syst 19(3):191\u2013233","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1021\/mp100208f","volume":"8","author":"M Henriksen-Lacey","year":"2010","unstructured":"Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstr\u00f8m T, Agger EM, Andersen P et al (2010a) Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3\u03b2-[N-(N\u2032, N\u2032-dimethylaminoethane) carbomyl] cholesterol (DC-Chol), and 1, 2-dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Mol Pharm 8:153\u2013161","journal-title":"Mol Pharm"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2010.03.027","volume":"145","author":"M Henriksen-Lacey","year":"2010","unstructured":"Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstr\u00f8m T, Agger EM, Andersen P et al (2010b) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 145:102\u2013108","journal-title":"J Control Release"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"e80579","DOI":"10.1371\/journal.pone.0080579","volume":"8","author":"T Hoang","year":"2013","unstructured":"Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK et al (2013) ESAT-6 (EsxA) and TB10. 4 (EsxH) based vaccines for pre-and post-exposure tuberculosis vaccination. PLoS One 8:e80579","journal-title":"PLoS One"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","volume":"72","author":"L Holten-Andersen","year":"2004","unstructured":"Holten-Andersen L, Doherty T, Korsholm K, Andersen P (2004) Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect Immun 72:1608\u20131617","journal-title":"Infect Immun"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/1556-276X-9-434","volume":"9","author":"Y Hu","year":"2014","unstructured":"Hu Y, Ehrich M, Fuhrman K, Zhang C (2014) In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters. Nanoscale Res Lett 9:434","journal-title":"Nanoscale Res Lett"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/jphp.12173","volume":"66","author":"MJ Hussain","year":"2014","unstructured":"Hussain MJ, Wilkinson A, Bramwell VW, Christensen D, Perrie Y (2014) Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants. J Pharm Pharmacol 66:358\u2013366","journal-title":"J Pharm Pharmacol"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.micinf.2010.11.002","volume":"13","author":"B-Y Jeon","year":"2011","unstructured":"Jeon B-Y, Kim S-C, Eum S-Y, Cho S-N (2011) The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. Microbes Infect 13:284\u2013290","journal-title":"Microbes Infect"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.4161\/hv.26136","volume":"9","author":"VB Joshi","year":"2013","unstructured":"Joshi VB, Geary SM, Salem AK (2013) Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Hum Vaccin Immunother 9:2584\u20132590","journal-title":"Hum Vaccin Immunother"},{"key":"9_CR34","first-page":"223","volume":"3","author":"SM Karimi","year":"2016","unstructured":"Karimi SM, Sankian M, Khademi F, Tafaghodi M (2016) Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant\/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen. Nanomed J 3:223\u2013229","journal-title":"Nanomed J"},{"issue":"2","key":"9_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","volume":"25","author":"SH Kaufmann","year":"2013","unstructured":"Kaufmann SH (2013) Tuberculosis vaccines: time to think about the next generation. Semin Immunol 25(2):172\u2013181. \n                  https:\/\/doi.org\/10.1016\/j.smim.2013.04.006","journal-title":"Semin Immunol"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11033-016-4024-9","volume":"43","author":"A Kebriaei","year":"2016","unstructured":"Kebriaei A, Derakhshan M, Meshkat Z, Eidgahi MRA, Rezaee SA, Farsiani H et al (2016) Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Mol Biol Rep 43:911\u2013922","journal-title":"Mol Biol Rep"},{"key":"9_CR37","first-page":"133","volume":"3","author":"F Khademi","year":"2016","unstructured":"Khademi F, Derakhshan M, Sadeghi R (2016) The role of toll-like receptor gene polymorphisms in tuberculosis susceptibility: a systematic review and meta-analysis. Rev Clin Med 3:133\u2013140","journal-title":"Rev Clin Med"},{"key":"9_CR38","first-page":"15","volume":"6","author":"F Khademi","year":"2017","unstructured":"Khademi F, Yousefi-Avarvand A, Derakhshan M, Meshkat Z, Tafaghodi M, Ghazvini K et al (2017a) Mycobacterium tuberculosis HspX\/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli. Rep Biochem Mol Biol 6:15\u201321","journal-title":"Rep Biochem Mol Biol"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18869\/modares.iem.3.1.25","volume":"3","author":"F Khademi","year":"2017","unstructured":"Khademi F, Yousefi-Avarvand A, Derakhshan M, Vaez H, Sadeghi R (2017b) Middle east Mycobacterium tuberculosis antibiotic resistance: a systematic review and meta-analysis. Infect Epidemiol Med 3:25\u201335","journal-title":"Infect Epidemiol Med"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajps.2014.06.002","volume":"9","author":"M-G Kim","year":"2014","unstructured":"Kim M-G, Park JY, Shon Y, Kim G, Shim G, Oh Y-K (2014) Nanotechnology and vaccine development. Asian J Pharm Sci 9:227\u2013235","journal-title":"Asian J Pharm Sci"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/10611860801900462","volume":"16","author":"DJ Kirby","year":"2008","unstructured":"Kirby DJ, Rosenkrands I, Agger EM, Andersen P, Coombes AG, Perrie Y (2008) PLGA microspheres for the delivery of a novel subunit TB vaccine. J Drug Target 16:282\u2013293","journal-title":"J Drug Target"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/CVI.00006-10","volume":"17","author":"K Kolibab","year":"2010","unstructured":"Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL (2010) Highly persistent and effective prime\/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol 17:793\u2013801","journal-title":"Clin Vaccine Immunol"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4161\/hv.27121","volume":"10","author":"H Kong","year":"2014","unstructured":"Kong H, Dong C, Xiong S (2014) A novel vaccine p846 encoding Rv3615c, Mtb10. 4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection. Hum Vaccin Immunother 10:378\u2013390","journal-title":"Hum Vaccin Immunother"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","volume":"23","author":"JA Langermans","year":"2005","unstructured":"Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R et al (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23:2740\u20132750","journal-title":"Vaccine"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","volume":"24","author":"W Li","year":"2007","unstructured":"Li W, Szoka FC (2007) Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 24:438\u2013449","journal-title":"Pharm Res"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","volume":"73","author":"Q Li","year":"2011","unstructured":"Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z et al (2011) Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Scand J Immunol 73:568\u2013576","journal-title":"Scand J Immunol"},{"key":"9_CR47","first-page":"1670","volume":"12","author":"X Liu","year":"2016","unstructured":"Liu X, Peng J, Hu L, Luo Y, Niu H, Bai C et al (2016) A multistage Mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. Hum Vaccin Immunother 12:1670\u20131677","journal-title":"Hum Vaccin Immunother"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1016\/j.vaccine.2009.08.018","volume":"27","author":"Y Luo","year":"2009","unstructured":"Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W et al (2009) Fusion protein Ag85B-MPT64 190\u2013198-Mtb8. 4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Vaccine 27:6179\u20136185","journal-title":"Vaccine"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/jps.22427","volume":"100","author":"SE McNeil","year":"2011","unstructured":"McNeil SE, Rosenkrands I, Agger EM, Andersen P, Perrie Y (2011) Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. J Pharm Sci 100:1856\u20131865","journal-title":"J Pharm Sci"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","volume":"39","author":"A Mosavat","year":"2016","unstructured":"Mosavat A, Soleimanpour S, Farsiani H, Sadeghian H, Ghazvini K, Sankian M et al (2016) Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infect Genet Evol 39:163\u2013172","journal-title":"Infect Genet Evol"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","volume":"29","author":"H Niu","year":"2011","unstructured":"Niu H, Hu L, Li Q, Da Z, Wang B, Tang K et al (2011) Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10. 4\u2013HspX. Vaccine 29:9451\u20139458","journal-title":"Vaccine"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tube.2003.08.011","volume":"84","author":"NM Nor","year":"2004","unstructured":"Nor NM, Musa M (2004) Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine. Tuberculosis 84:102\u2013109","journal-title":"Tuberculosis"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","volume":"69","author":"AW Olsen","year":"2001","unstructured":"Olsen AW, van Pinxteren LA, Okkels LM, Rasmussen PB, Andersen P (2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 69:2773\u20132778","journal-title":"Infect Immun"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","volume":"72","author":"AW Olsen","year":"2004","unstructured":"Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P (2004) Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72:6148\u20136150","journal-title":"Infect Immun"},{"key":"9_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002607","volume":"8","author":"TH Ottenhoff","year":"2012","unstructured":"Ottenhoff TH, Kaufmann SH (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8:e1002607","journal-title":"PLoS Pathog"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","volume":"60","author":"LJ Peek","year":"2008","unstructured":"Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915\u2013928","journal-title":"Adv Drug Deliv Rev"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.micpath.2012.12.002","volume":"58","author":"JM Pitt","year":"2013","unstructured":"Pitt JM, Blankley S, McShane H, O\u2019Garra A (2013) Vaccination against tuberculosis: how can we better BCG? Microb Pathog 58:2\u201316","journal-title":"Microb Pathog"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2172-9-38","volume":"9","author":"RS Rosada","year":"2008","unstructured":"Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Z\u00e1rate-Blad\u00e9s CR, Fonseca DM et al (2008) Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol 9:38","journal-title":"BMC Immunol"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcis.2011.09.040","volume":"373","author":"RS Rosada","year":"2012","unstructured":"Rosada RS, Silva CL, Santana MHA, Nakaie CR, de la Torre LG (2012) Effectiveness, against tuberculosis, of pseudo-ternary complexes: peptide-DNA-cationic liposome. J Colloid Interface Sci 373:102\u2013109","journal-title":"J Colloid Interface Sci"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1128\/IAI.73.9.5817-5826.2005","volume":"73","author":"I Rosenkrands","year":"2005","unstructured":"Rosenkrands I, Agger EM, Olsen AW, Korsholm KS, Andersen CS, Jensen KT et al (2005) Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect Immun 73:5817\u20135826","journal-title":"Infect Immun"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1016\/j.vaccine.2005.03.040","volume":"23","author":"SB Sable","year":"2005","unstructured":"Sable SB, Verma I, Khuller G (2005) Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. Vaccine 23:4175\u20134184","journal-title":"Vaccine"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/2051013614541440","volume":"2","author":"RA Schwendener","year":"2014","unstructured":"Schwendener RA (2014) Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccin 2:159\u2013182","journal-title":"Ther Adv Vaccin"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","volume":"99","author":"S Soleimanpour","year":"2015","unstructured":"Soleimanpour S, Farsiani H, Mosavat A, Ghazvini K, Eydgahi MRA, Sankian M et al (2015) APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Appl Microbiol Biotechnol 99:10467\u201310480","journal-title":"Appl Microbiol Biotechnol"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/09687860600790537","volume":"23","author":"DP Vangasseri","year":"2006","unstructured":"Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD Jr, Huang L (2006) Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385\u2013395","journal-title":"Mol Membr Biol"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","volume":"4","author":"A Vartak","year":"2016","unstructured":"Vartak A, Sucheck SJ (2016) Recent advances in subunit vaccine carriers. Vaccine 4:12","journal-title":"Vaccine"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/resp.12052","volume":"18","author":"CC Wang","year":"2013","unstructured":"Wang CC, Zhu B, Fan X, Gicquel B, Zhang Y (2013) Systems approach to tuberculosis vaccine development. Respirology 18:412\u2013420","journal-title":"Respirology"},{"key":"9_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072745","volume":"8","author":"Q Xin","year":"2013","unstructured":"Xin Q, Niu H, Li Z, Zhang G, Hu L, Wang B et al (2013) Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice. PLoS One 8:e72745","journal-title":"PLoS One"},{"key":"9_CR68","first-page":"158","volume":"66","author":"F Xiong","year":"2011","unstructured":"Xiong F, Mi Z, Gu N (2011) Cationic liposomes as gene delivery system: transfection efficiency and new application. Pharmazie 66:158\u2013164","journal-title":"Pharmazie"}],"container-title":["Reviews of Physiology, Biochemistry and Pharmacology","Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/112_2018_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T13:22:12Z","timestamp":1558358532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/112_2018_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319952871","9783319952888"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/112_2018_9","relation":{},"ISSN":["0303-4240","1617-5786"],"issn-type":[{"value":"0303-4240","type":"print"},{"value":"1617-5786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"27 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}